Cargando…

REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes

Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of...

Descripción completa

Detalles Bibliográficos
Autores principales: Land, Kevin J., Boeras, Debrah I., Chen, Xiang-Sheng, Ramsay, Andrew R., Peeling, Rosanna W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097043/
https://www.ncbi.nlm.nih.gov/pubmed/30546093
http://dx.doi.org/10.1038/s41564-018-0295-3
_version_ 1783510945196146688
author Land, Kevin J.
Boeras, Debrah I.
Chen, Xiang-Sheng
Ramsay, Andrew R.
Peeling, Rosanna W.
author_facet Land, Kevin J.
Boeras, Debrah I.
Chen, Xiang-Sheng
Ramsay, Andrew R.
Peeling, Rosanna W.
author_sort Land, Kevin J.
collection PubMed
description Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes.
format Online
Article
Text
id pubmed-7097043
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70970432020-03-26 REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes Land, Kevin J. Boeras, Debrah I. Chen, Xiang-Sheng Ramsay, Andrew R. Peeling, Rosanna W. Nat Microbiol Perspective Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes. Nature Publishing Group UK 2018-12-13 2019 /pmc/articles/PMC7097043/ /pubmed/30546093 http://dx.doi.org/10.1038/s41564-018-0295-3 Text en © Springer Nature Limited 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Perspective
Land, Kevin J.
Boeras, Debrah I.
Chen, Xiang-Sheng
Ramsay, Andrew R.
Peeling, Rosanna W.
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title_full REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title_fullStr REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title_full_unstemmed REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title_short REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
title_sort reassured diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097043/
https://www.ncbi.nlm.nih.gov/pubmed/30546093
http://dx.doi.org/10.1038/s41564-018-0295-3
work_keys_str_mv AT landkevinj reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes
AT boerasdebrahi reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes
AT chenxiangsheng reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes
AT ramsayandrewr reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes
AT peelingrosannaw reassureddiagnosticstoinformdiseasecontrolstrategiesstrengthenhealthsystemsandimprovepatientoutcomes